Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Huaren versus Baxter peritoneal dialysate in CAPD patients with end-stage renal disease
ChiCTR-TRC-13003001Phase 4Completed
- Sponsor
- Chinese PLA General Hospital
- Start
- Jan 2013
- Modality
- Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Huaren Peritoneal Dialysate and peritoneal dialysis solution in end-stage kidney disease (ESKD) (2 arms), sponsored by Chinese PLA General Hospital. Primary endpoint: Survival rate. Started Jan 2013; status: completed.
02
Drugs
Huaren Peritoneal Dialysateperitoneal dialysis solution
03
Conditions
end-stage kidney disease (ESKD)
Beyond the preview
Go deeper on ChiCTR-TRC-13003001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-13003001.